| International Nonproprietary N |
Recommended INN: List 81 | WHO Drug Information,2019,33,1 | 查看 |
| Consultation Documents |
Environmental aspects of good manufacturing practices | WHO Drug Information,2019,33,1 | 查看 |
| Consultation Documents |
Policy on remaining shelf life of medical products | WHO Drug Information,2019,33,1 | 查看 |
| Consultation Documents |
Moxifloxacin hydrochloride | WHO Drug Information,2019,33,1 | 查看 |
| Consultation Documents |
Moxifloxacin tablets | WHO Drug Information,2019,33,1 | 查看 |
| Consultation Documents |
The International Pharmacopoeia | WHO Drug Information,2019,33,1 | 查看 |
| Regulatory News |
Towards a global competency framework for regulators of medical products | WHO Drug Information,2019,33,1 | 查看 |
| School of INN |
The School of International Nonproprietary Names | WHO Drug Information,2019,33,1 | 查看 |
| International Nonproprietary N |
Proposed INN: List 120 | WHO Drug Information,2018,32,4 | 查看 |
| ATC/DDD classification |
ATC/DDD classification (final) | WHO Drug Information,2018,32,4 | 查看 |
| ATC/DDD classification |
ATC/DDD classification (temporary) | WHO Drug Information,2018,32,4 | 查看 |
| Consultation documents |
Revision of the monograph on levofloxacin tablets | WHO Drug Information,2018,32,4 | 查看 |
| Consultation documents |
Revision of the monograph on levofloxacin | WHO Drug Information,2018,32,4 | 查看 |
| Consultation documents |
Polymorphism | WHO Drug Information,2018,32,4 | 查看 |
| Consultation documents |
Revision of the monograph on ethinylestradiol | WHO Drug Information,2018,32,4 | 查看 |
| ICDRA |
18thInternational Conference of Drug Regulatory Authorities (ICDRA) Recommendations | WHO Drug Information,2018,32,4 | 查看 |
| International Nonproprietary N |
Recommended INN: List 80 | WHO Drug Information,2018,32,3 | 查看 |
| Consultation documents |
Guidelines on Validation – Appendix 6 Qualification | WHO Drug Information,2018,32,3 | 查看 |
| Consultation documents |
Guidelines on Validation – Appendix 4 Analytical Method Validation | WHO Drug Information,2018,32,3 | 查看 |
| Consultation documents |
Limit Test for Heavy Metals | WHO Drug Information,2018,32,3 | 查看 |
